Arcus Biosciences (RCUS) Equity Income (2018 - 2020)
Powered by 
Analysis
Arcus Biosciences (RCUS) Equity Income (2018 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Arcus Biosciences | 3.73 Bn | 3.03 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 1.23 Mn |
| Jun 30, 2020 | -131,000.00 |
| Mar 31, 2020 | -482,000.00 |
| Sep 30, 2019 | -357,000.00 |
| Jun 30, 2019 | -412,000.00 |
| Mar 31, 2019 | -431,000.00 |
| Dec 31, 2018 | -323,000.00 |
| Sep 30, 2018 | -186,000.00 |
| Jun 30, 2018 | -151,000.00 |
| Mar 31, 2018 | -226,000.00 |